The Australian Defence Force (ADF) has commissioned Monash University to study the damaging impacts of low-level blast exposure on the brains of defence personnel, as recommended by the Royal Commission into Defence and Veteran Suicide.

Monash University researchers have just launched Australia’s first clinical trial to test whether the psychedelic drug psilocybin is an effective treatment for persisting post-concussion symptoms.

Researchers at Monash University and The Alfred are pioneering a method of analysing blood samples to diagnose concussion in people aged over 60, the world’s most at-risk group for the condition.

Monash University’s Faculty of Medicine, Nursing and Health Sciences is proud to announce the 2026 recipients of the Monash Medicine Early Career Research Excellence Program (ECREP), celebrating an outstanding cohort of Early Career

Australia has the highest rate of methamphetamine use disorder in the world, yet treatment outcomes remain consistently poor. Researchers say one of the key reasons people struggle during recovery is the emergence of severe impulsivity.

A world-first concussion and head impact study led by Monash University will assess the efficacy of headgear during elite and community football and rugby games.

Professor Terence O’Brien has been successfully appointed as Monash University’s next Dean, Sub-Faculty of Translational Medicine and Public Health, within the Faculty of Medicine, Nursing and Health Sciences (MNHS).

Three exceptional researchers from the School of Translational Medicine were honoured with ECR Publication Prizes.

Neuroscience has taken centre stage at Monash today, with delegates from all over the world convening at the Velos Accelerator in the Monash Technology Precinct, Clayton, to shine a spotlight on the latest discoveries, technologies and